The Council for Scientific and Industrial Research (CSIR), and Tata Medical and Diagnostics Ltd (Tata MD), the new healthcare venture from the Tata Group have teamed up to boost the COVID-19 testing capacity across Tier-II and Tier-III towns as well as rural areas, across India. The two organisations are developing capacity to handle any future surge in the COVID-19 testing requirements.
- Read more about CSIR and Tata MD partners to augment COVID-19 testing
- Log in or register to post comments
source https://www.pharmatutor.org/node/36625
No comments:
Post a Comment